- Home
- SVM vs PRTA Comparison
SVM vs PRTA Comparison
Compare SVM & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVM
- PRTA
- Stock Information
- Founded
- SVM N/A
- PRTA 2012
- Country
- SVM Canada
- PRTA Ireland
- Employees
- SVM N/A
- PRTA N/A
- Industry
- SVM Precious Metals
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- SVM Basic Materials
- PRTA Health Care
- Exchange
- SVM Nasdaq
- PRTA Nasdaq
- Market Cap
- SVM 906.7M
- PRTA 809.8M
- IPO Year
- SVM N/A
- PRTA N/A
- Fundamental
- Price
- SVM $4.06
- PRTA $5.72
- Analyst Decision
- SVM Strong Buy
- PRTA Buy
- Analyst Count
- SVM 1
- PRTA 9
- Target Price
- SVM $6.25
- PRTA $27.67
- AVG Volume (30 Days)
- SVM 7.5M
- PRTA 2.5M
- Earning Date
- SVM 08-12-2025
- PRTA 08-07-2025
- Dividend Yield
- SVM 0.62%
- PRTA N/A
- EPS Growth
- SVM 40.00
- PRTA N/A
- EPS
- SVM 0.28
- PRTA N/A
- Revenue
- SVM $298,895,000.00
- PRTA $137,935,000.00
- Revenue This Year
- SVM $1.10
- PRTA N/A
- Revenue Next Year
- SVM $26.47
- PRTA $119.20
- P/E Ratio
- SVM $14.46
- PRTA N/A
- Revenue Growth
- SVM 38.90
- PRTA 54.55
- 52 Week Low
- SVM $2.87
- PRTA $4.32
- 52 Week High
- SVM $5.32
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- SVM 49.08
- PRTA 44.43
- Support Level
- SVM $4.20
- PRTA $4.95
- Resistance Level
- SVM $4.51
- PRTA $5.53
- Average True Range (ATR)
- SVM 0.19
- PRTA 0.34
- MACD
- SVM -0.01
- PRTA 0.24
- Stochastic Oscillator
- SVM 12.13
- PRTA 78.29
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).